News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
148 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17849)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (8)
2 (146)
3 (83)
4 (7)
5 (215)
6 (50)
7 (4)
8 (8)
9 (162)
10 (176)
11 (140)
12 (138)
13 (79)
14 (3)
15 (2)
16 (148)
17 (198)
18 (151)
19 (189)
20 (83)
21 (5)
22 (6)
23 (133)
24 (183)
25 (184)
26 (185)
27 (83)
28 (1)
29 (3)
30 (152)
31 (162)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Business
Sono-Tek Sales Grew 8% to $2.7 Million in First Quarter Fiscal 2019
First quarter gross margin was 47.1%
July 16, 2018
·
10 min read
Policy
OD-OS Achieves Revocation of Iridex MicroPulse™ Patent and Clears Path to Tissue-Friendly Treatment With Navilas® in Clinical Practice
The Navilas® Laser System makes tissue-sparing treatment of retinal diseases more predictable, and paves the way for widespread adoption of microsecond pulse protocols in standard clinical practice.
July 16, 2018
·
2 min read
Pharm Country
Pharmaceutical industry gets first open source platform for Level 4 serialization
‘QU4RTET,’ the only software of its kind, gives pharmaceutical packagers unprecedented flexibility in deployment and configuration
July 16, 2018
·
2 min read
Genetown
Homology Medicines Announces Peer-Reviewed Publication Demonstrating Efficient and Precise In Vivo Gene Editing Capabilities of Nuclease-Free Technology Platform
Homology Medicines, Inc. announced a peer-reviewed publication demonstrating that Homology’s technology induces efficient and precise in vivo gene editing.
July 16, 2018
·
6 min read
Business
Globus Medical Schedules Second Quarter 2018 Earnings Release and Conference Call
Globus Medical, Inc. will announce its financial results for the second quarter ended June 30, 2018 after the market close on Wednesday, August 1, 2018.
July 16, 2018
·
1 min read
Policy
Patient Advocates Call on Trump Administration to Defend Patients with Preexisting Conditions in Court
National Patient Advocate Foundation (NPAF) called on the Trump Administration to reverse its decision to argue in court that the preexisting conditions protections enshrined in the Affordable Care Act (ACA) should be overturned.
July 16, 2018
·
1 min read
Deals
Nasdaq Schedules Hearing to Consider Neovasc’s Appeal of Delisting Determination
Neovasc Inc. has scheduled an oral hearing for August 30, 2018
July 16, 2018
·
8 min read
Business
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2018 Financial Results
Cryo-Cell International, Inc. announced results for the fiscal second quarter ended May 31, 2018.
July 16, 2018
·
3 min read
Pharm Country
Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of Valsartan and Valsartan Hydrochlorothiazide Tablets
Teva Pharmaceuticals USA today confirmed a voluntary recall to the consumer / user level of 29 lots of single and 51 lots of combination valsartan medicines distributed under the Actavis label in the U.S. due to the detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) manufactured by Zhejiang Huahai Pharmaceutical.
July 16, 2018
·
8 min read
Policy
Cal/OSHA Produces Fact Sheet, Poster for Preventing Work-Related Injuries to Housekeeping Workers
Cal/OSHA has produced a fact sheet and poster to help employers in the hotel and lodging industry comply with a new regulation to prevent work-related injuries suffered by housekeeping workers.
July 16, 2018
·
3 min read
Previous
14 of 15
Next